Asset Details
Do you wish to reserve the book?
DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia
Do you wish to request the book?
DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia
2012
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ Aged
/ Antimetabolites, Antineoplastic - therapeutic use
/ Azacitidine - analogs & derivatives
/ Azacitidine - therapeutic use
/ Biological and medical sciences
/ DNA (Cytosine-5-)-Methyltransferases - genetics
/ Female
/ Hematologic and hematopoietic diseases
/ Humans
/ Kinases
/ Leukemia
/ Leukemia, Myeloid, Acute - drug therapy
/ Leukemia, Myeloid, Acute - genetics
/ Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
/ Male
/ Medicine
/ Mutation
/ Oncology
/ Patients
